Targeted CAR-T Cells
Phase 1Cell therapy
Targeted CAR-T Cells is one of 5 biologic programs targeting Advanced Solid Cancers. It is currently in Phase 1.
1
Indications
1
Total Trials
1
Active Trials
4
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
6 competitors in Advanced Solid Cancers
#DrugCompanyPhaseTrials
1Opdivo
Bristol-Myers SquibbPhase 2
Yervoy
Bristol-Myers SquibbPhase 2
Copanlisib Hydrochloride
NNational Cancer Institute (NCI)
Phase 2
ND-003
SShenzhen NewDEL Biotech, Co., Ltd
Phase 1
Targeted CAR-T Cells
HHainan Cancer Hospital
Phase 1
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Targeted CAR-T Cells. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Cell therapy[2]
- Highest Phase
- Phase 1[1]
- Company
- HHainan Cancer Hospital